Alvotech (ALVO) Long-Term Deferred Tax (2021 - 2026)
Alvotech (ALVO) posted Long-Term Deferred Tax of $192.9 million for Q1 2026, little changed on a QoQ basis from $192.2 million in Q4 2025, and down 38.84% year-over-year from $315.3 million in Q1 2025.
Alvotech (ALVO) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends
Alvotech's Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $192.9 million for Q1 2026.
- Quarterly Long-Term Deferred Tax fell 38.84% year-over-year to $192.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $192.9 million (down 38.84% YoY) and the FY2025 annual result came in at $192.2 million, down 35.58% from the prior year.
- Long-Term Deferred Tax was $192.9 million for Q1 2026 at Alvotech, roughly flat from $192.2 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $340.5 million in Q3 2025 and bottomed at $188.0 million in Q2 2022.
- A 5-year average of $273.6 million and a median of $302.5 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax jumped 47.88% — and 2026, when it slumped 38.84%.
- Alvotech's Long-Term Deferred Tax stood at $209.5 million in 2022, then jumped by 47.88% to $309.8 million in 2023, then declined by 3.69% to $298.4 million in 2024, then slumped by 35.58% to $192.2 million in 2025, then rose by 0.34% to $192.9 million in 2026.
- Business Quant data shows ALVO's Long-Term Deferred Tax at $192.9 million in Q1 2026, $192.2 million in Q4 2025, and $340.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.86 Mn |
| Dec 31, 2025 | 192.21 Mn |
| Sep 30, 2025 | 340.50 Mn |
| Jun 30, 2025 | 338.33 Mn |
| Mar 31, 2025 | 315.35 Mn |
| Dec 31, 2024 | 298.36 Mn |
| Sep 30, 2024 | 320.37 Mn |
| Jun 30, 2024 | 306.64 Mn |
| Mar 31, 2024 | 318.22 Mn |
| Dec 31, 2023 | 309.81 Mn |
| Jun 30, 2023 | 260.30 Mn |
| Mar 31, 2023 | 239.71 Mn |
| Dec 31, 2022 | 209.50 Mn |
| Jun 30, 2022 | 187.98 Mn |
| Dec 31, 2021 | 170.42 Mn |